Nuveen Asset Management, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$3,174,659
-33.1%
1,011,038
+9.9%
0.00%
-50.0%
Q2 2023$4,745,146
+466482.7%
919,602
+376.4%
0.00%
Q1 2023$1,017
+71.2%
193,033
-8.6%
0.00%
Q4 2022$594
-99.9%
211,160
-17.9%
0.00%
Q3 2022$1,068,000
-23.7%
257,262
-26.1%
0.00%
-100.0%
Q2 2022$1,399,000
-16.3%
348,097
+6.2%
0.00%0.0%
Q1 2022$1,672,000
-31.0%
327,819
-15.8%
0.00%0.0%
Q4 2021$2,423,000
-30.1%
389,548
+18.6%
0.00%0.0%
Q3 2021$3,466,000
-6.2%
328,520
+26.0%
0.00%0.0%
Q2 2021$3,697,000
-11.6%
260,708
+2.3%
0.00%0.0%
Q1 2021$4,184,000
-66.4%
254,951
-57.6%
0.00%
-75.0%
Q4 2020$12,434,000
+562.1%
600,671
+143.5%
0.00%
+300.0%
Q3 2020$1,878,000
+3.3%
246,722
+13.1%
0.00%0.0%
Q2 2020$1,818,000
+159.3%
218,234
+54.0%
0.00%
Q1 2020$701,000
+33.0%
141,749
+6.2%
0.00%
Q4 2019$527,000
-9.6%
133,488
-30.4%
0.00%
Q3 2019$583,000
+4.9%
191,831
+51.9%
0.00%
Q2 2019$556,000126,2900.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,932,607$40,643,00015.56%
Lamond Capital Partners LLC 711,533$14,964,00015.19%
Polaris Venture Management Co. V, L.L.C. 1,230,009$25,867,00011.54%
NOTTINGHAM ADVISORS, INC. 171,985$3,617,0000.60%
Portolan Capital Management 122,518$2,577,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 160,000$3,365,0000.33%
Rotella Capital Management, Inc. 18,461$388,0000.32%
Monashee Investment Management LLC 28,834$606,0000.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 335,498$7,056,0000.24%
BAILARD, INC. 55,000$1,157,0000.18%
View complete list of OCULAR THERAPEUTIX INC shareholders